A股異動 | 愷英網絡(002517.SZ)漲超4% 與騰訊計算機簽訂《<藍月傳奇2>獨家代理協議》
格隆匯11月9日丨愷英網絡(002517.SZ)今日高開高走,盤中一度漲超7%,現漲幅收窄至4.45%,報5.63元,最新總市值121億元。愷英網絡上週五(6日)晚間發公告稱,近日,紹興盛意與騰訊計算機簽訂《獨家代理協議》,紹興盛意將移動終端版本遊戲《藍月傳奇2》在中國大陸地區的獨家代理權授予騰訊計算機。合同期限為合同生效日開始,截至授權產品商業化上線滿3年。公告稱,如果本次授權能順利執行,將有利於促進授權產品在中國大陸地區的運營與推廣。此次合作協議的簽署預計對公司本年度及未來會計年度營業收入和淨利潤等有積極影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.